T-Cells Targeted With Anti-Cd3 X Anti-Her2 Bispecific Antibody For Treatment Of Women With Stage Iv Breast Cancer (Phase I): Clinical And Immune Function Results.

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 0|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要